Continue reading here:
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma

See the rest here:
Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® – an Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate...

Continue reading here:
Virbac : Declaration of the number of shares and voting rights 03/2024

See the original post here:
Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor

Read more here:
Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of...

Continue reading here:
Epic Bio Announces Robust Slate of Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

The rest is here:
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth

Continue reading here:
Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024

See the original post here:
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting

See the original post here:
QIAGEN N.V. to release results for Q1 2024 and hold webcast

View original post here:
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models

View original post here:
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head...

Visit link:
Imugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024

Visit link:
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103

Follow this link:
EUROAPI streamlines its Executive Committee to improve focus and efficiency

See the article here:
Medicenna Presents Updated Preclinical Data on MDNA113, a First-in-Class, Targeted and Masked Bi-functional anti-PD1-IL2 Superkine, at the 2024 Annual...

The rest is here:
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®

Here is the original post:
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results

Go here to read the rest:
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet

Here is the original post:
Nuvectis Pharma to Present at the 36th Annual Roth Conference